Hoffmann, Ethan
Nomikos, George G.
Kaul, Inder
Raines, Shane
Wald, Jeff
Bullock, Amy
Sankoh, Abdul J.
Doherty, James
Kanes, Stephen J.
Colquhoun, Helen
Funding for this research was provided by:
Sage Therapeutics, Inc.
Article History
First Online: 24 July 2019
Compliance with ethical standards
:
: Ethan Hoffmann, Amy Bullock, Abdul J. Sankoh, James Doherty, Stephen J. Kanes, and Helen Colquhoun are employees of Sage Therapeutics, Inc., with stock/stock options. George G. Nomikos was formerly an employee of Sage Therapeutics, Inc., with stock/stock options during the conduct of this study. He is currently in Clinical Development with Biogen, Inc. Inder Kaul is an employee of Kaul Consulting, LLC, which was contracted by Sage Therapeutics, Inc. for this study. Shane Raines is an employee of 2b Analytics, LLC, which was contracted by Sage Therapeutics, Inc. for this study. Jeff Wald is an employee of qPharmetra, LLC, which was contracted by Sage Therapeutics, Inc. for this study.